NL-OMON35080CompletedPhase 4
Pilot study to compare straylight perception in pseudophakic subjects with different intraocular lenses - Clear Multifocal Vision (CMV)
AMO Groningen BV0 sites15 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •1. Age 18 or greater
- •2. Bilateral cataracts for which phacoemulsification cataract extraction and posterior chamber IOL implantation have been planned.
- •3. Visual potential in each eye of 0.8 (20/25 Snellen) or better as determined by surgeon*s estimation
- •4. Normal corneal topography with preoperative corneal astigmatism of 1.5 D or less (or the ability to manage astigmatism to 1.0 or less postoperatively by incision placement)
- •5. Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
- •6. Signed informed consent
Exclusion Criteria
- •1. Concurrent participation or participation during the last 30 days in any other clinical trial
- •2. Use of systemic or ocular medications that may affect vision (the use of any miotic agent is specifically contraindicated)
- •3. Acute or chronic disease or illness that would increase the operative risk or confound the outcome(s) of the study (e.g., immunocompromised, connective tissue disease, diabetes, etc.)
- •4. Uncontrolled systemic or ocular disease
- •5. Irregular astigmatism
- •6. Requiring an intraocular lens <16.0 or >26.0 diopters
- •7. History of ocular trauma or prior ocular surgery
- •8. Corneal abnormalities such as stromal, epithelial or endothelial dystrophies
- •9 10. Uncontrolled ocular hypertension or glaucomatous changes in the retina
- •11. Intraocular inflammation or recurrent ocular inflammatory condition
- •12. Known pathology that may potentially affect vision
- •13. Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils)
- •14. Capsule or zonule abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, an eccentric anterior capsulorhexis, or posterior capsule defects
- •15. Retinal changes that may affect vision or that may require surgical intervention during the course of the study (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.)
- •16. Planned moving or moving to another home address during the study.
Investigators
Similar Trials
Not yet recruiting
Phase 2
A study to evaluate the reduction of dark spots on the faceCTRI/2023/09/057260ightinderm
Completed
Not Applicable
A pilot study to monitor light exposure and sleep wake cycles in post-operative cardiac patients and its implications for hospital stay and depression.ight exposure in the hospital environmentLight exposure in the hospital environmentOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12609000180213niversity of Auckland20
Recruiting
Not Applicable
Quantifying stimulus evoked electroencephalographic variability in mild dementiaNeurological - DementiasNeurological - Alzheimer's diseaseDementiaAlzheimer's DiseaseACTRN12623000285651St Vincent's Hospital Melbourne48
Not yet recruiting
Not Applicable
Research on the effect of light stimulation control throughout the day on photoreceptors related to circadian rhythm based on metamerism for change in illuminant design method on human healthhealthy memJPRN-UMIN000042141Kyoto University20
Not yet recruiting
Phase 3
A study to understand the differences in the cell cycle phase distribution and establish dormancy signature in patients on sequential vsconcurrent chemo-endocrine therapy in hormone receptor positive and HER2 negative non-metastatic breast cancerCTRI/2022/07/044399Tata Memorial Centre